All studies
Ongoing, recruitingTherapeutic use (Phase IV)Interventional
A phase IV randomised, double-blind, parallel-design, controlled multi-center trial of a NOVel moisturiser for Atopic dermatitis: effect on relapse prevention in children, NOVA II
At a glance
Status
Ongoing, recruiting
Phase
Therapeutic use (Phase IV)
Sponsor
Aco Hud Nordic AB
Enrolment target
270
Start
06 Dec 2022
What is this study about?
Relapse of atopic eczema, measured as a hazard ratio. Definition of relapse is an episode that, from the participants/participants’ parent(s) and/or legal guardian(s)’s perspective, requires escalation of treatment of the study area eczemas. Date of relapse will be noted in the eDiary and confirmed by the Investigator.
Who may be eligible?
Age any to any · Sex: All
Locations (2)
- —Germany
- —Sweden
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.